Martin Beyer

Dr. @MerajNeyazi educating us on single cell transcriptomic signatures of cardiac sarcoidosis and fantastic questions by the audience! @GOuditResearch @MartinBeyer_ @UKEHamburg @harvardmed @AHAScience @American_Heart #AHA2024 #sarcoidosis

🫀 A routine checkup revealed a malignant tumor in the left ventricle of a 71-year-old with dilated cardiomyopathy. After minimally-invasive surgery, chemo, and proton therapy, he remains cancer-free at 2 years! Read the full case report here 👉 shorturl.at/fFrxl

Dr. @ben_bay will present “Impact of Polyvascular Disease on Mortality in Patients Undergoing Percutaneous Coronary Intervention for Unprotected Left Main Coronary Artery Disease” at #ACC24. Be sure to join him. @ACCinTouch @IcahnMountSinai #Cardiology #CardioX #CardioTwitter

@Lenard08808061 @Nils_Soensen @larawald @SebLudwig1 @MoritzSeiffert @c_vlgmnn @NiklasSchofer @BenediktKoell @pecha_simon @JohannPetersen @TillDemal

@Lenard08808061 @Nils_Soensen @larawald @SebLudwig1 @MoritzSeiffert @c_vlgmnn @NiklasSchofer @BenediktKoell @pecha_simon

Excited to share that our Hamburg TAVI experience in patients with septal hypertrophy has been published in CRC! 👉TAVI is technically feasible and demonstrates acute efficacy in selected patients with SH. A Heart Team discussion remains mandatory! 🔗shorturl.at/fgwG1

The 2024 Annual Meeting was a resounding success! 🎉 Thanks to all attendees, speakers, and organizers for making it unforgettable. Looking forward to seeing you all at #DGHTG2025! 🚀

🫀 Outstanding contribution from @ShekharSaha91 investigating mitral valve endocarditis trends at #STS2024 🇩🇪 The study compares outcomes of MVr (8.9%) vs. MVR (91.1%) using CAMPAIGN registry data (n=4917) 📊 MVr showed superior survival rates at 1 (78%) and 5 years (70%).

@Lenard08808061 @SebLudwig1 @modine_thomas @FabienPraz @MattiAdam_MD @MoritzSeiffert @NiklasSchofer @HWienemann @pecha_simon

Excited to share our analysis of secondary retensioning of a tether-based device for transapical TMVI, now published @EJCTS. doi.org/10.1093/ejcts/…

⏳ In less then 48 hours HAMBURG VALVE REPAIR - Training Course for Mitral and Aortic Valve Repair starts !!! 22.05 – 23.05.2023 Don't miss out and register NOW ✅ ❗Registration: hamburgvalve.de ➡ Come to Hamburg or join us online 🔥🔥 Mit 22 CME-Punkte zertifiziert

Transcatheter MV Replacement vs Best Medical Therapy? Some Clues dlvr.it/SpB4s5

Ring for mitral valve repair

„Cusp overlap technique for self-expanding Evolut transcatheter aortic valves is associated with a significant and relevant reduction of PPI and paravalvular regurgitation rates without an increase in complication rates.“ Out now in @EuroInterventio eurointervention.pcronline.com/article/cusp-o…

@Florentine_Klee @DennisLawin @NMerke @schaefers_hans @JFdgthg @asmae_gassa For choosing the right prosthesis. For all those who work in structural heart teams

Neujahrsumfrage:Welche Apps nutzt Ihr im herzchirurgischen Alltag? Was hilft den Young Cardiac Surgeons wirklich? Schreibt eure Empfehlungen in die Kommentare! #HelpWelcome #CTsurgery (In Anlehung an den Tweet von @DennisLawin )😉 @NMerke @schaefers_hans @JFdgthg @asmae_gassa

#ICYMI, watch the replay of this #PCRwebinar on management of #tricuspid valve regurgitation with @Lenard08808061, @juliendreyfus1, Michael Borger, Felix Kreidel, @dottormaisano & Georg Nickenig. 📺 pcronline.com/Webinars/PCR-W… #MedEd

Wir durften am vergangenen Wochenende in der herzchirurgischen Klinik-Kassel zu Gast sein. Im Rahmen unserer Arbeitssitzung diskutierten wir spannende und wichtige Themen der modernen Herzchirurgie. Wir wollen die Zukunft auch weiterhin aktiv mitgestalten! 🫀

Wir hatten gestern einen erfolgreichen ersten Tag unserer Arbeitssitzung in Münster, mit wichtigen Diskussionen über die zukünftige herzchirurgische Weiterbildung und einem Skills Lab!🫀 Herzlichen Dank an Prof. Martens für Ihren Besuch und die spannende Diskussion @UK_Muenster